Leguisan, Gorita A.
HRN: 08-14-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/13/2023
07/19/2023
IV
1.5g
Q6H
Cellulitis, Left Thigh
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes